Conflict of Interest
The authors declare no conflict of interest.
Author Contributions
JF was involved in design, literature search, discussion, first draft, and critical comments.
Letter to the Editor
With interest we read the article by Kania et al. about a 19‐year female diagnosed with SARS‐CoV‐2 vaccination‐triggered acute, disseminated, encephalomyelitis (ADEM) upon clinical presentation (headache, fever, neck/back pain, nausea, vomiting, and urinary retention), cerebral and spinal magnetic resonance imaging (MRI) findings (multiple, poorly demarcated, hyperintense lesions on T2‐weighted and fluid‐attenuated inversion recovery (FLAIR) images located in both hemispheres, pons, medulla oblongata, and cerebellum, which partially enhanced), and cerebro‐spinal fluid (CSF) investigations (pleocytosis of 294/3, elevated protein). 1 Two weeks prior to presentation she had undergone a first vaccination with an mRNA‐based SARS‐CoiV‐2 vaccine (Moderna). 1 She partially recovered under methyl‐prednisolone. 1 The study is appealing but raises concerns and comments.
We do not agree that ADEM may be only due to viral infections or vaccinations. 1 ADEM has been also reported following radio‐chemotherapy, 2 bacterial infections with E. coli, 3 synthetic cannabinoids, 4 viper venoms, 5 herbal extracts, 6 hyponatriemia, or genetic disease, such as X‐lined Charcot Marie Tooth disease due to GJB1 mutations. 7
Differential diagnoses were not appropriately excluded. We should know if immune encephalitis was excluded by determination of specific antibodies associated with immune encephalitis, such as NMDA, AMPAR, LGI1, NLBP12, etc. 8 We should know if multifocal PRES due to porphyria had been excluded. 9 Was the patient ever tested for SARS‐CoV‐2? The vaccination can be ineffective.
We should know for how long the patient had received ceftriaxone and acyclovir. Is it conceivable that the patient did not actually profit from steroids but rather from the antibiotic or the antiviral medication? How can the authors be sure that ADEM was due to the vaccination and not due to a viral agent, remaining undetected in the CSF? Oligoclonal bands were negative in the index patient suggesting that the condition was not immunogenic but rather infectious.
We should be informed if the CSF was tested for RNA of SARS‐CoV‐2. The CSF had been previously shown to be positive for virus RNA in single patients. 10 However, most previous studies on SARS‐CoV‐2 infection associated ADEM have shown that the CSF was negative for virus RNA. 11 We should be informed if the intra‐thecal IgG production was elevated or not.
We should be informed about the imaging findings using imaging modalities other than T2/FLAIR.
Overall, the elegant study has several limitations, which challenge the results and their interpretation. Infectious agents need to be more thoroughly excluded. Differentials of ADEM need to be more widely considered. More details about imaging findings should be provided.
Informed Consent
Informed consent was obtained.
The study was approved by the institutional review board.
Funding Information:
No funding was received.
References
- 1. Kania K, Ambrosius W, Tokarz Kupczyk E, Kozubski W. Acute disseminated encephalomyelitis in a patient vaccinated against SARS‐CoV‐2. Ann Clin Transl Neurol. 2021; doi: 10.1002/acn3.51447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Esakia T, Antia T, Janelidze M, Mariamidze A, Okujava M. Acute disseminated encephalomyelitis following chemoradiotherapy in an adult patient with nasopharyngeal cancer. Cureus. 2021;13(3):e14137. doi: 10.7759/cureus.14137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Balamurugesan K, Ponprabha R, Davis P. An interesting case of acute disseminated encephalomyelitis following E. coli infection. J Family Med Prim Care. 2019;8(1):292‐295. doi: 10.4103/jfmpc.jfmpc_402_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Samra K, Boon IS, Packer G, Jacob S. Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoid black mamba . BMJ Case Rep. 2017;2017:bcr2016218431. doi: 10.1136/bcr-2016-218431 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Xu A, Shan R, Huang D, Zhou J, Keenoo A, Qin J. Case report: acute demyelinating encephalomyelitis following viper bite. Medicine (Baltimore). 2016;95(45):e5310. doi: 10.1097/MD.0000000000005310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Kaymakamzade B, Karabudak R, Kurne AT, Nurlu G. acute disseminated encephalomyelitis after oral therapy with herbal extracts: a case report. Balkan Med J. 2016;33(3):366‐369. doi: 10.5152/balkanmedj.2016.140420 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kim JK, Han SA, Kim SJ. X‐linked Charcot‐Marie‐Tooth disease with GJB1 mutation presenting as acute disseminated encephalomyelitis‐like illness: a case report. Medicine (Baltimore). 2017;96(49):e9176. doi: 10.1097/MD.0000000000009176 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Pillai SC, Hacohen Y, Tantsis E, et al. Infectious and autoantibody‐associated encephalitis: clinical features and long‐term outcome. Pediatrics. 2015;135(4):e974‐e984. doi: 10.1542/peds.2014-2702 [DOI] [PubMed] [Google Scholar]
- 9. Rasheed F, Mehdi QS, Bhatti S, Ali Khan MM. Posterior reversible encephalopathy syndrome in a patient with variegate porphyria: a case report. Cureus. 2018;10(9):e3351. doi: 10.7759/cureus.3351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Espíndola OM, Brandão CO, Gomes YCP, et al. Cerebrospinal fluid findings in neurological diseases associated with COVID‐19 and insights into mechanisms of disease development. Int J Infect Dis. 2021;102:155‐162. doi: 10.1016/j.ijid.2020.10.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Vraka K, Ram D, West S, et al. Two paediatric patients with encephalopathy and concurrent COVID‐19 infection: two sides of the same coin? Case Rep Neurol Med. 2021;2021:6658000. doi: 10.1155/2021/6658000 [DOI] [PMC free article] [PubMed] [Google Scholar]